PIEMONTESE, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 8.527
AS - Asia 3.593
EU - Europa 3.129
SA - Sud America 1.100
Continente sconosciuto - Info sul continente non disponibili 738
AF - Africa 165
OC - Oceania 10
Totale 17.262
Nazione #
US - Stati Uniti d'America 8.214
SG - Singapore 1.331
IT - Italia 1.281
BR - Brasile 874
CN - Cina 845
HK - Hong Kong 414
SE - Svezia 338
RU - Federazione Russa 326
VN - Vietnam 316
FR - Francia 259
GB - Regno Unito 225
DE - Germania 214
IN - India 169
CA - Canada 146
BD - Bangladesh 134
FI - Finlandia 132
UA - Ucraina 105
ID - Indonesia 80
AR - Argentina 64
CO - Colombia 44
IQ - Iraq 44
EC - Ecuador 42
TR - Turchia 41
AT - Austria 34
ZA - Sudafrica 34
JP - Giappone 30
MX - Messico 30
PL - Polonia 29
CI - Costa d'Avorio 28
ES - Italia 28
IE - Irlanda 24
NL - Olanda 23
VE - Venezuela 22
MA - Marocco 21
PH - Filippine 21
BE - Belgio 19
PT - Portogallo 19
SV - El Salvador 19
TT - Trinidad e Tobago 17
EG - Egitto 16
NI - Nicaragua 16
CH - Svizzera 15
CL - Cile 15
MY - Malesia 15
CR - Costa Rica 14
KE - Kenya 14
SA - Arabia Saudita 14
JM - Giamaica 13
PE - Perù 13
PY - Paraguay 13
GT - Guatemala 12
PR - Porto Rico 12
AE - Emirati Arabi Uniti 11
GP - Guadalupe 11
LT - Lituania 11
PK - Pakistan 11
IR - Iran 10
KR - Corea 10
UZ - Uzbekistan 10
AU - Australia 9
TN - Tunisia 9
HN - Honduras 8
IL - Israele 8
JO - Giordania 8
OM - Oman 8
AL - Albania 7
AZ - Azerbaigian 7
CW - ???statistics.table.value.countryCode.CW??? 7
NP - Nepal 7
TW - Taiwan 7
UY - Uruguay 7
DZ - Algeria 6
KZ - Kazakistan 6
BO - Bolivia 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
GA - Gabon 5
LB - Libano 5
SN - Senegal 5
TH - Thailandia 5
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
GR - Grecia 4
MD - Moldavia 4
PA - Panama 4
SC - Seychelles 4
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
KW - Kuwait 3
LY - Libia 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BB - Barbados 2
BF - Burkina Faso 2
BG - Bulgaria 2
BS - Bahamas 2
Totale 16.494
Città #
Ashburn 1.117
Singapore 633
San Jose 630
Fairfield 609
Chandler 476
Woodbridge 439
Hong Kong 405
Milan 349
Houston 333
Council Bluffs 293
Cambridge 287
Nyköping 269
Seattle 250
Beijing 220
Jacksonville 210
Ann Arbor 202
Wilmington 193
Dallas 139
New York 134
Ho Chi Minh City 126
Bari 123
Rome 118
Lauterbourg 115
Roxbury 113
Lawrence 112
Los Angeles 103
Santa Clara 98
Nanjing 91
São Paulo 83
Boardman 68
Des Moines 68
Princeton 64
Washington 64
Hanoi 62
Helsinki 62
Inglewood 56
Naples 53
Figino 50
Munich 50
Jakarta 49
Chicago 48
Brooklyn 47
Frankfurt am Main 41
Atlanta 36
London 35
Buffalo 34
Orem 34
Columbus 33
Jiaxing 33
Moscow 31
North Bergen 31
Rio de Janeiro 31
Turin 30
Marseille 29
Tokyo 29
Abidjan 28
Hebei 28
Toronto 27
Montreal 26
San Francisco 26
Brasília 25
San Diego 25
Baghdad 24
Belo Horizonte 24
Chennai 24
Dong Ket 24
Falkenstein 24
Shanghai 24
Warsaw 24
Boydton 23
Dublin 23
Bologna 22
Fragagnano 21
Guangzhou 21
Poplar 21
Brussels 19
Denver 19
Johannesburg 19
Lisbon 19
Phoenix 19
Nanchang 18
Paris 17
Changsha 16
Managua 16
San Salvador 16
Basingstoke 15
Dhaka 15
Redwood City 15
Boston 14
Florence 14
Langenzersdorf 14
Manchester 14
Medellín 14
Nuremberg 14
Quito 14
Redondo Beach 14
Amsterdam 13
Haiphong 13
Augusta 12
Cairo 12
Totale 10.307
Nome #
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 245
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 220
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity 217
Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer’s Disease 212
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 208
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 200
Deep eutectic solvents as novel and effective extraction media for quantitative determination of Ochratoxin A in wheat and derived products 192
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 186
A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders 185
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 180
An innovative approach for the treatment of Alzheimer’s disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventions 175
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists 175
An update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligands 175
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 172
Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s Disease 172
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 171
Bone-seeking matrix metalloproteinase inhibitors for the treatment of skeletal malignancy 168
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 166
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 165
Reduction of aflatoxins in apricot kernels by electronic and manual color sorting 163
Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer′s disease therapy 162
New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge 159
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 158
Occurrence of patulin in conventional and organic fruit products in Italy and subsequent exposure assessment 158
Processo e impianto per il trattamento di mosti e vini 158
Miscele eutettiche come solventi biocompatibili a basso impatto ambientale per l’estrazione e la determinazione di metaboliti secondari fungini in matrici alimentari 157
New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation 152
Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidates 149
Deep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2‐Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil‐Like Compounds 148
Plant Food Supplements with Antioxidant Properties for the Treatment of Chronic and Neurodegenerative Diseases: Benefits or Risks? 147
Natural plant food supplements and food coloring agents derived from Vitis Vinifera: a new source of human exposure to ochratoxin A 147
Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer’s disease 147
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 145
Design, synthesis, and in vitro evaluation of hydroxybenzimidazole-donepezil analogues as multitarget-directed ligands for the treatment of Alzheimer's disease 144
Deep Eutectic Solvents as effective media for the extraction of small molecules from natural sources 144
A Chemical Modification of a Peroxisome Proliferator-Activated Receptor Pan Agonist Produced a Shift to a New Dual Alpha/Gamma Partial Agonist Endowed with Mitochondrial Pyruvate Carrier Inhibition and Antidiabetic Properties 143
Open tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection 143
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 143
Hydroxypyridinone derivatives: a fascinating class of chelators with therapeutic applications - an update 140
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression 138
Importance of Biometals as Targets in Medicinal Chemistry: An Overview about the Role of Zinc (II) Chelating Agents 138
Exploiting hydroxyphenylbenzimidazol-based hybrids for metal-modulation in potential anti-Alzheimer´s drugs 135
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 134
Aspergillus carbonarius proteases and their possible activity in Ochratoxin A degradation 133
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 130
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 130
A Chemoinformatics Search for Peroxisome Proliferator-Activated Receptors Ligands Revealed a New Pan-Agonist Able to Reduce Lipid Accumulation and Improve Insulin Sensitivity 130
Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity. 129
Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand–macromolecule interaction. 129
Natural Compounds for the Prevention and Treatment of Cardiovascular and Neurodegenerative Diseases 129
Identification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated Phosphorylation 128
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 126
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 126
The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs 125
Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer's agents 121
Effect of gaseous ozone treatments on DON, microbial contaminants and technological parameters of wheat and semolina 121
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 121
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 120
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 119
A NEW ANTIDIABETIC AGENT SHOWING PPARα/γ DUAL AGONISM AND MITOCHONDRIAL PYRUVATE CARRIER INHIBITION 117
Natural scaffolds with potential metal chelating activity for the multi-target therapy of Alzheimer's Disease: a preliminary study 111
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 110
Climate change effect on ochratoxin A production and gene expression in Aspergillus carbonarius 109
Food Industry Byproducts as Starting Material for Innovative, Green Feed Formulation: A Sustainable Alternative for Poultry Feeding 108
Effects of temperature and water activity change on ecophysiology of ochratoxigenic Aspergillus carbonarius in field-simulating conditions 107
Synthesis of Chelating Agents Potentially Useful as Markers for Neurodegenerative Diseases Using Deep Eutectic Solvents 105
Natural compounds as FAAH inhibitors: preliminary screening and potential developments 105
Can foods influence the onset and progress of neurodegenerative diseases? 105
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 105
Plant Food Supplements and food coloring agents derived from Vitis vinifera, a new source of human exposure to Ochratoxin A 104
Making traditional Italian almond sweets: effects on aflatoxins levels and distribution in final and waste products. 101
Ozone treatment as a possible strategy for reductiono of mycotoxins, pesticides and microbial contamination in durum wheat 100
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 100
Green Methods to Recover Bioactive Compounds from Food Industry Waste: A Sustainable Practice from the Perspective of the Circular Economy 98
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 98
Identification of Natural Scaffolds as New Multi-Functional Agents for the Treatment of Alzheimer’s Disease 97
Food Coloring Agents and Plant Food Supplements Derived from Vitis vinifera: A New Source of Human Exposure to Ochratoxin A 97
3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate 96
Synthesis of New Copper and Zinc Chelators with Potential Therapeutic Application in the Neurodegenerative Diseases 95
Mixing Traditional and Innovative Approaches for the Prevention and Treatment of Neurodegenerative and Cardiovascular Diseases: An Overview 92
Synthesis and biological activity evaluation of novel diphenylmethane-based ligands for PPARα and PPARγ 91
Deep Eutectic Solvents as effective media for the synthesis of Donepezil structure-based hybrids with metal-chelating properties 91
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 90
Processing of almonds and apricot kernels: new insights on evolution of aflatoxins 89
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function 89
Novel small molecules for PPARs modulation and their potential use for treatment of metabolic disorders 89
Sintesi e Relazioni Struttura-Attività di Nuovi Analoghi Chirali dell'Acido Clofibrico ad Attività Agonista sui Recettori PPARa e PPARg 89
Lentil (Lens culinaria) and its by-products inclusion in livestock nutrition: present insights and emerging trends in rabbit and poultry system 86
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 86
Role of copper chelating agents: between old applications and new perspectives in neuroscience 85
IDENTIFICATION OF A NOVEL PPARRα/γ DUAL AGONIST SHOWING ANTIDIABETIC EFFECTS AND ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF ABLE TO BIND TO CANONICAL AND ALLOSTERIC SITES OF PPARγ 85
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 85
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 84
From classical MTDLs to a semi-synthetic innovative green approach: nature-inspired design as a new intriguing opportunity for new anti-Alzheimer’s drugs 83
Occurrence and characterization of penicillium species isolated from post-harvest apples in lebanon 83
Repurposing Rivastigmine Anti-AD Drug By Aryloxyacetic Hybridization: Biometal Chelation And Potential Increased Anti-Amyloidogenic Ability 82
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 77
Discovery of a dual PPARα/γ partial agonist displaying antisteatotic and antidiabetic properties: in silico studies and X-ray structure determination 76
PROGETTAZIONE, SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI OSSIMMINICI AD ATTIVITA’ AGONISTA DUALE PPARα/γ. 76
Therapeutic potential of PPARs ligands: towards new fascinating goals 75
Totale 13.004
Categoria #
all - tutte 67.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.617


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022664 0 0 0 20 34 52 27 41 40 44 130 276
2022/20231.340 214 122 90 97 146 172 15 161 236 18 42 27
2023/2024628 36 82 35 35 59 147 44 38 27 26 29 70
2024/20252.644 180 78 219 123 97 155 278 243 149 174 297 651
2025/20265.940 690 298 436 844 577 282 546 215 581 634 238 599
2026/20272.055 214 320 713 808 0 0 0 0 0 0 0 0
Totale 17.262